MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Axitinib

Axitinib 1mg tablets

No stability information

Stability notes for Axitinib 1mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Axitinib 1mg tablets
Axitinib 1mg tablets (Accord-UK Ltd)
Axitinib 1mg tablets (Genus Pharmaceuticals Ltd)
Axitinib 1mg tablets (Pfizer Ltd)
Axitinib 1mg tablets (Teva UK Ltd)
Inlyta 1mg tablets (Pfizer Ltd)

Axitinib 3mg tablets

No stability information

Stability notes for Axitinib 3mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Axitinib 3mg tablets
Axitinib 3mg tablets (Accord-UK Ltd)
Axitinib 3mg tablets (Genus Pharmaceuticals Ltd)
Axitinib 3mg tablets (Pfizer Ltd)
Axitinib 3mg tablets (Teva UK Ltd)
Inlyta 3mg tablets (Pfizer Ltd)

Axitinib 5mg tablets

No stability information

Stability notes for Axitinib 5mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Axitinib 5mg tablets
Axitinib 5mg tablets (Accord-UK Ltd)
Axitinib 5mg tablets (Genus Pharmaceuticals Ltd)
Axitinib 5mg tablets (Pfizer Ltd)
Axitinib 5mg tablets (Teva UK Ltd)
Inlyta 5mg tablets (Pfizer Ltd)

Axitinib 7mg tablets

No stability information

Stability notes for Axitinib 7mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Axitinib 7mg tablets
Axitinib 7mg tablets (Genus Pharmaceuticals Ltd)
Axitinib 7mg tablets (Pfizer Ltd)
Axitinib 7mg tablets (Teva UK Ltd)
Inlyta 7mg tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.